# Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)

> **NCT04121065** · — · UNKNOWN · sponsor: **Neuromed IRCCS** · enrollment: 150 (estimated)

## Conditions studied

- Relapsing Multiple Sclerosis

## Interventions

- **PROCEDURE:** Blood withdrawal

## Key facts

- **NCT ID:** NCT04121065
- **Lead sponsor:** Neuromed IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-07
- **Primary completion:** 2024-10
- **Final completion:** 2025-06
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04121065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04121065, "Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04121065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*